View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.
Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.
Responses must be submitted before 23:59 on 26th September 2025
https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey
Vetoquinol has introduced a new smaller pack size for Reprocine, to help prevent wastage. The new 6 x 10ml pack is now available from wholesalers.
Reprocine is licensed in the cow for uterine atony during the puerperal (post-parturient) period, placental retention as a consequence of uterine atony and initiation of milk ejection in a stress-induced agalactia or in conditions requiring udder emptying. In the sow, Reprocine is licensed for uterine atony during the puerperal period also, supportive therapy of mastitis-metritis-agalactia (MMA) syndrome, initiation of milk ejection and for shortening of parturition period. Reprocine is an intraveneous or intramuscular injection and has the added advantage of no milk or meat withdrawal.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "The new pack size reduces wastage which provides an instant cost-effective advantage.
"Reprocine is rapidly distributed and slowly eliminated. Efficient parturition and milk ejection is essential for newborn welfare and ultimately provides an economic benefit. Reprocine can be utilised in many reproductive associated conditions."
Reprocine is also available in 50ml bottles.
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
This, says the company, will make vaccination easier for vets and clients.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand.
Each box contains 10 individual doses which can be given to pet rabbits from 30 days of age.
The original survey was sent last year to more than 5,000 UK-registered veterinary surgeons and veterinary nurses who gained their qualification from a non-UK EU institution, with a response rate of around 55%.
This year the Institute for Employment Studies (IES), on behalf of the RCVS, contacted over 6,000 veterinary surgeons and almost 50 veterinary nurses – including those previously surveyed as well as EU registrants who have joined since the last survey – who trained in non-UK EU countries to seek their views on the implications of Brexit for European veterinary professionals.
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The aim of this survey is to gain a greater understanding of the views and expectations of our EU colleagues now that certain elements of the UK’s withdrawal process from the European Union, as well as the timing, have become clearer. The survey will also be looking for the views of colleagues on how the College has addressed the challenges of Brexit so far.
"It is particularly important that those who responded to last year’s survey do so this year because the aim is to get a sense of how their views and plans are shifting as the Brexit process moves forward."
As with last year’s survey, the views collated through the consultation will help the College understand the immediate and longer-term impact of the UK’s exit from the EU, gather evidence that could be used to make a case for special treatment of veterinary professionals with regard to future immigration policies and allow the College to provide informed advice to European veterinary professionals as they make decisions about their future careers.
Dr Tufnell added: "I would strongly encourage EU veterinary professionals to respond to this survey, even if they didn’t do so last year, as their views really do matter to us and really do have an impact on our Brexit policies and the views we put forward to the government in these critical times."
The deadline for sending responses to the IES is Wednesday 18 July 2018 and all data will be managed and analysed by IES, an independent not-for-profit research institute, on a confidential basis with no individual responses being seen by the RCVS.
The College says it intends to conduct a third survey when the terms of the UK’s withdrawal from the EU, and the impact of this on non-UK EU nationals, are better defined.
The symposium, which will be held on Tuesday 24 September 2019, at Church House in London, will bring together researchers interested in all aspects of veterinary professionals’ wellbeing and mental health. It will feature plenary speakers from mental health research, including:
Professor Neil Greenberg: Sustaining resilience at work – what does the evidence tell us works?, Professor of Defence Mental Health, Consultant Academic Psychiatrist at King’s College London, Chair of the Royal College of Psychiatrists’ (RCP) Special Interest Group in Occupational Psychiatry.
Professor Alexandra Pitman: The impact of veterinarian suicide on colleagues, Associate Professor in Psychiatry in the UCL Division of Psychiatry and an Honorary Consultant Psychiatrist at Camden and Islington NHS Foundation Trust.
Professor Stuart Reid: The Mind Matters Initiative – what we’ve achieved so far, Principal, Royal Veterinary College, Chair of the Mind Matters Initiative.
Presentations should be in the format of a 15-minute oral presentation or an A1 poster.
Those wishing to apply should submit an abstract clearly marked ‘poster’ or ‘oral presentation’. The title should be 15 words or fewer. The abstract should include author(s) first name(s), followed by surname(s), institution of affiliation and country. The body of the text should be no longer than 250 words and include: background; clear and explicit aims and objectives, hypotheses or research questions; methods; results; discussion; and conclusion.
All abstracts should be submitted as Word documents to Rosie Allister on rosie.allister@gmail.com no later than 23:59 (GMT) on Friday 19 April 2019.
Applicants will be notified if they have been successful within 14 days of this date. Speakers whose applications are successful will receive complimentary registration for the symposium, not including travel and accommodations costs.
A small number of travel bursaries are available for students, people with lived experience of mental health problems, and people who are unwaged, who would not otherwise be able to attend. For further details, please contact Lisa Quigley, Mind Matters Initiative Manager, on l.quigley@rcvs.org.uk.
The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
The nomination period runs until 5pm on Tuesday 31 January 2018. In order to stand, candidates will need to submit a nomination form along with contact details, a short biography and a statement, and supply a high-resolution digital photograph.
Each candidate also needs two nominators, who should be veterinary surgeons who are on the College’s Register but are not current RCVS Council members.
Professor Stephen May, RCVS President, said: "I myself have been an elected Council member since 2012, and it has given me tremendous opportunity to get involved with a whole range of subjects, including my particular interests, undergraduate education and lifelong learning. It’s incredibly rewarding to see how the decisions you make during your time on Council can really benefit the profession, and I would encourage anyone who shares an interest in the future of our profession, whether that be about graduate outcomes, practice standards, the wider veterinary team or the effects of Brexit, for example, to stand for election."
Although the RCVS is planning the elections as usual, it is concurrently preparing for a change to its governance arrangements, including a reduction in the size of the Council, as agreed in March 2016.
Commenting on the Legislative Reform Order (LRO) that will be required to amend the Veterinary Surgeons Act 1966, RCVS Registrar Eleanor Ferguson said: "This is a complex matter and, unfortunately, due to unavoidable delays associated with the 2017 General Election and the impact of preparing for the UK’s departure from the European Union, the LRO has not yet completed the legislative process.
"This means that whilst we will be running the elections on the basis that there will be six elected places available, as per the old size and structure, it should be expected that under the new size and structure, only three places will ultimately be available."
Meanwhile, due to comparable changes to the governance of the Veterinary Nurses Council, including a reduction in its number, there will be no 2018 VN Council elections as the outgoing members will not need to be replaced.
The RCVS Council election period will start around mid-March and voting will close at 5pm on Friday 27 April 2018.
Nomination forms, guidance notes and frequently asked questions are available for prospective RCVS Council candidates at www.rcvs.org.uk/rcvscouncil18.
The new service will offer all the chemo and surgical options.
Matthew (pictured right) said: "At Eastcott, we have amazing facilities and staff to care for pets with cancer, so we are proud to launch this comprehensive new oncology service.
"We have a custom-designed chemotherapy room, multiple sterile theatres - including our interventional radiology theatre - and state-of-the-art imaging facilities, with a 64-slice CT scanner and advanced ultrasound equipment.
"We are able to manage the full range of tumour types including maxillofacial tumours, from diagnosis to treatment.
"We use a variety of techniques to allow accurate staging, including minimally invasive biopsy and lymph node harvesting, as well as sentinel lymph node mapping and advanced medical imaging.
"Treatment options include advanced soft tissue surgical oncology and the full range of medical oncology. This may involve standard and metronomic chemotherapy, intracavitary chemotherapy and immunotherapy, such as the melanoma vaccine.
"We pride ourselves on helping owners understand our treatment plan through the whole process and emphasise the importance of making the right decisions to maintain the welfare of our patients.”
For more information, visit www.eastcottreferrals.co.uk.
The service will be run by European and RCVS recognised specialist in Soft Tissue Surgery, Jane Ladlow, and will begin taking referrals from October 28th.
Jane has nearly 20 years’ experience as a specialist clinician, researcher, teacher and lecturer.
Her main focus for the last 10 years has been upper airway disease in dogs. As the clinical lead of the Cambridge Brachycephalic Obstructive Airway Syndrome (BOAS) Research Group, she has been instrumental in the introduction of objective, non-invasive assessments of airway function, identifying risk factors for BOAS, clinical diagnosis, breeding guidelines and the development of new surgical techniques (laser turbinectomy and laryngeal surgeries).
She has extensive experience of general surgery, and particularly enjoys oncology surgery, with an emphasis on treatments that are kind to owners and animals. Jane was the 2019 recipient of the BSAVA Simon Award for outstanding contributions in the field of veterinary surgery.
Jane said, “The team at HSR demonstrate a drive for excellence, both clinically and in providing the best experience for clients and their pets. I’m excited to start working as part of the innovative and collaborative team of surgeons, nurses and support staff.”
Director and orthopaedic surgery specialist, Michael Hamilton, said: “We’re absolutely delighted to welcome Jane to the team here. Her work has revolutionised the way we diagnose and manage BOAS. Continual learning and innovation are core to our practice, and we know Jane will be a strong driving force helping us continue providing the best outcomes for clients and their pets.”
For more information, visit: www.hamiltonspecialists.vet
Owners are being asked to provide a photo or video and a brief description that capture what it is like to live with and care for an older dog.
Dr Carri Westgarth, a senior lecturer in human-animal interaction at the University of Liverpool, has been awarded a citizen science grant from PetSavers to run the project. She plans to use the information gathered to help develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Carri said: “Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time the dog may spend in poor health. It may be difficult for us to distinguish between the signs of serious age-related diseases and normal age-related changes in our dogs."
PetSavers says the data will contribute to our investigations of owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
Carri added: "Improving discussions between owners and veterinary professionals about senior dog care will help to increase owner understanding and involvement in care decisions for their pet. The resulting early detection of health problems should bring significant improvement to the quality of life of senior pets and the dog-owner relationship.
"Any adult UK residents who (currently or recently) live with an aged dog/s of any breed/s or health status are encouraged to participate by choosing an image or short video and telling us about it."
The research team will then analyse the submitted text and media for common themes. They may also use anonymised selected quotes to illustrate important findings in research publications such as scientific papers or conference presentations.
If you know any owners who might like to participate, do share this link with them: https://bit.ly/PetSaversOAPsPhoto
For more information, visit: https://www.petsavers.org.uk/our-research/oldagepets
Data collection will close on Friday 10th July 2020.
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
References
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his practice’s equipment and facilities in working order such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Monday 15 May was Mr Seymour-Hamilton’s fifth application for restoration, with previous applications being submitted but refused in July 1995, June 2010, January 2015 and March 2016. However, as the Committee made its decision on the merits of the case before it, those previous applications were not considered as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research, citing his treatment of one of his dogs as evidence.
The Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient; and his lack of evidence of public support for him or his work.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has very great concerns about the future of the welfare of animals in the event of the applicant being permitted to have his name restored to the Register. He has made it clear that whilst he has no intention to return to routine veterinary general practice, he would intend to treat animals and to continue his research using animals. The Committee observes that were he to be restored to the Register, there would be no power to prevent the applicant practising as a veterinary surgeon in any way he may choose."
He added: "The applicant has now been off the Register for nearly 23 years. It will be apparent to anyone that the veterinary profession today is in many respects different from what it was 23 years ago, (eg: in terms of medical understanding and its own regulation). The Committee is far from persuaded that the passage of 23 years has not had a negative impact on the applicant’s ability to practise safely and competently as a veterinary surgeon at this present time."
Mark will be cycling the 100-mile route, the same as was used in the 2012 London Olympics, on Sunday 30th July.
Mark said: "Having worked in veterinary medicine for more than 20 years, I have have come to appreciate that it is a career with highs as well as lows. That some days are going to be pure gold, but others are likely to be emotionally tough and stressful. In those times mental health can be tested and that's where services like Mind really come into their own. I'd like to advertise their work and raise some money at the same time by cycling this event for them.
"I have wanted to support Mind for a long time and the Prudential 100 is a local event that gives me an opportunity to support their great work."
If you'd like to support Mark's efforts, you can do so at: http://uk.virginmoneygiving.com/markturner31
For the 10,000 steps challenge, the practice has split into teams of eight which will compete against each other for a weekly prize for the team that collectively walks the furthest.
The practice is also encouraging colleagues to participate in daily wellbeing sessions, including interval training and a mindfulness programme, in conjunction with healthcare partner Vitality.
Mark Goodfellow, Head of Oncology at Davies and Mental Health First Aider said: “Commitment to high standards and dedication to patient care can lead to long working hours.
"Couple this with sick patients, distressed clients and end of life decision-making and the outcome can be feelings of failure, hopelessness and compassion fatigue.
"Simply taking time to walk and share experiences with a colleague can be an unburdening in itself. A problem shared with the right person is a problem halved.”
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Vet Futures has published the results of a survey of the profession in which only half of veterinary surgeons who graduated within the last eight years say their career has matched their expectations.
The online survey gathered views from 892 veterinary students (via the Association of Veterinary Students) and 1,973 veterinary surgeons who had graduated within the last eight years, during May and June this year.
Although 37% of graduates reported that their working lives had met their expectations, and a further 13% said it had exceeded them, this left 50% partly or wholly unsatisfied. Furthermore, 10% said they were considering leaving the profession entirely.
The RCVS and the BVA say the results should be a “wakeup call” to the profession.
Vets who have been qualified for five years or more were least optimistic about the future, rating their opportunities for career progression less positively than more recent graduates. They were also least likely to feel that their degree had prepared them for their current work. Meanwhile, only 34% of students felt that their degree was preparing them ‘very well’ for the work they wanted to do.
73% of students intended to work in the UK, with most aspiring to work in small animal/exotic or mixed practice, although one in 10 was as yet undecided. Of the students, 45% said they wanted to become practice owners or partners. Clearly the reality is proving less enticing, because only 25% graduates shared the same aspiration. In addition, nearly double the number of graduates said they wanted to work outside clinical practice (18%), compared to students.
When looking for a job, the three factors that both graduates and students agreed would have the greatest influence on their choice of career were intellectual satisfaction, location and a supportive environment.
This last requirement chimes with the fact that among the most popular suggestions for improvement to the veterinary degree were compulsory modules on managing stress, personal development and work-life balance, alongside more teaching of business and finance skills, and extra-mural studies (EMS) placements in a wider range of settings, such as industry.
BVA President, John Blackwell, said: “The drop off in career satisfaction for vets during this crucial first eight years in practice is something we can’t afford to ignore. It points to frustration over career development opportunities and dissatisfaction with support available in practice. For the veterinary profession to remain sustainable, and an attractive career choice for the best and brightest, we need to address these issues with some urgency.”
RCVS President, Dr Bradley Viner, said: “We clearly need to address the disconnect between expectation and reality for many recent graduates. Reviewing the educational foundation of the profession is a thread that runs through many of the proposed actions that will be outlined in the Vet Futures report due this autumn. The teaching and assessment of non-clinical skills – both as part of the undergraduate curriculum and within postgraduate education – will be important, as will be the promotion of non-clinical career pathways.”
The survey also covered issues such as students’ aspirations in terms of the type (size, ownership, sector) of practice in which they would like to work, and graduates’ future career plans. It also considers attitudes from both groups with respect to new technology.
The full research report “Voices from the future of the profession,” can be read at www.vetfutures.org.uk/resources.
The College has kicked off with questions and answers about the right to work in the UK and the impact on those currently studying to become a veterinary surgeon or planning to do so.
Although it's not yet possible to give definitive answers and there will doubtless be many more questions, the College says it will be keeping the new page updated as the situation unfolds.
The Q&A page can be found here: http://www.rcvs.org.uk/registration/about-the-rcvs-register/frequently-asked-questions-on-the-impact-of-the-eu-referendum/
To use the service, practices have to register for VetsDeliver via Easy Direct Debit (which handles payments), then configure the system for the number of consultation rooms needed and to add practice branding. The first consultation room costs £69 per month, with discounts for subsequent rooms.
Practices can promote the service to pet owners by sharing a link for appointments via social media, the practice website, or a mail out to clients.
Clients then follow the shared link, complete a form and book a consultation slot.
After the consultation, the practice can email a link to the pet owner so that they can pay for any medication.
Adrian Tantrum (that must have been quite a cross to bear at school), Head of the Companion Animal Business Unit at MSD Animal Health said: "As market leaders, with brands such as Bravecto, Nobivac and Caninsulin, we want to help practices adapt to the new normal.
"We have listened to feedback from practices around what they want from a telemedicine platform and worked with EDD to create a simple and easy to use service. This will allow practices to provide pet owners with the support they need, whether it be their parasiticide prescriptions or providing continuity of care for diabetic patients, and will of course bring much-needed cash flow into their practices.
"We've chosen Zoom for the video capabilities as it is one of the most popular video conference apps with millions of users worldwide, so we know it's familiar to most pet owners."
Adrian added: "As we all adjust to new ways of working we are putting in place a whole series of new services for practices that will help bring them closer to their clients and allow them to continue to provide pet owners with the expertise and support they need. Being able to see a vet 'face-to-face', if not in the flesh, will be reassuring for a lot of pet owners who will be worrying about both new and on-going conditions."
For more information, contact your MSD account manager.
The session will be led by Adam Gregory, Head Nurse, who has experience gained around the world both as a veterinary nurse and a zookeeper.
Adam will take attendees through the basic triaging steps to assess and review treatment that may be needed, as well as covering a range of common presenting problems.
Great Western Exotics says it will be a great opportunity for first opinion vets and nurses to become more familiar with the needs of these birds to ensure they receive the best treatment possible in emergency situations.
To sign up to the talk, email Jess: GWEreferrals@vets-now.com.
https://www.gwexotics.com
The two-year study aims to better understand the impact of the disease on horses’ and ponies’ quality of life and is hoped to improve monitoring and decision-making regarding treatment.
In particular, the study aims to develop a validated equine quality of life tool to assess the impact of the condition on an individual horse’s quality of life objectively.
This, it is hoped, will help support decision-making related to treatment and euthanasia options for horses and ponies diagnosed with PPID.
The research team is led by Aline Bouquet, PhD Candidate and Research Assistant, and supported by Professor Nicola Menzies-Gow, Professor in Equine Medicine and Professor Christine Nicol, Professor of Animal Welfare.
Participants can have horses and ponies with PPID as well as those without the condition and they must be older than ten years of age (the horses, that is)
The survey will take no longer than 15 minutes to complete, providing an assessment of the animal’s quality of life, clinical signs associated with PPID and any additional veterinary-related problems.
https://rvc.uk.com/PPID-survey-2023-stage1
https://www.rvc.ac.uk/research/projects/objective-assessment-of-the-quality-of-life-of-equines-with-pituitary-pars-intermedia-dysfunction
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.